anti egr1 Search Results


90
Bio-Techne corporation human egr1 antibody
Human Egr1 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+egr1/Human+EGR1+Antibody/bio-techne+corporation___af2818
Average 90 stars, based on 1 article reviews
human egr1 antibody - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

N/A
Identification and enumeration of EGR-1+ cells by flow cytometry
  Buy from Supplier

90
Bio-Rad rabbit anti egr1
Rabbit Anti Egr1, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+egr1/Rabbit+anti+EGR1/10__1172_slash_jci124030-219-44-58
Average 90 stars, based on 1 article reviews
rabbit anti egr1 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Boster Bio antibody against egr 1
Antibody Against Egr 1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+egr1/Anti-Egr1+Antibody+Picoband/pmc11268476__SC___015___D4SC01493F___s001-97-28-31
Average 90 stars, based on 1 article reviews
antibody against egr 1 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

86
Wanleibio egr1
The protein expression of emotion-related genes in the hippocampus. ( A ) The protein expression of BDNF, DCX, and <t>EGR1</t> in hippocampal tissues. ( B – D ) The protein density was quantified using Image J software. BA means baicalin (n = 3). Results are presented as mean ± SE. * p < 0.05, ** p < 0.01, *** p < 0.001. Absence of * indicates no significance.
Egr1, supplied by Wanleibio, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+egr1/anti+egr1/pmc12466348-22-0-8
Average 86 stars, based on 1 article reviews
egr1 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

90
GeneTex anti-egr1 antibody
The protein expression of emotion-related genes in the hippocampus. ( A ) The protein expression of BDNF, DCX, and <t>EGR1</t> in hippocampal tissues. ( B – D ) The protein density was quantified using Image J software. BA means baicalin (n = 3). Results are presented as mean ± SE. * p < 0.05, ** p < 0.01, *** p < 0.001. Absence of * indicates no significance.
Anti Egr1 Antibody, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+egr1/anti+egr1+antibody/pm35594155-49-84-87
Average 90 stars, based on 1 article reviews
anti-egr1 antibody - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

86
Affinity Biosciences anti targeting ngal2
The protein expression of emotion-related genes in the hippocampus. ( A ) The protein expression of BDNF, DCX, and <t>EGR1</t> in hippocampal tissues. ( B – D ) The protein density was quantified using Image J software. BA means baicalin (n = 3). Results are presented as mean ± SE. * p < 0.05, ** p < 0.01, *** p < 0.001. Absence of * indicates no significance.
Anti Targeting Ngal2, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+egr1/anti+egr1+targeting/pmc12333045-63-6-17
Average 86 stars, based on 1 article reviews
anti targeting ngal2 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Abmart Inc anti egr3 antibody
Gskj1 enhances H3K27me3 enrichment at <t>EGR3</t> and suppresses EGR3/c-FOS signaling to promote apoptosis and ferroptosis. A Volcano plot of differentially expressed genes (DEGs) in H69-AR cells treated with Gskj1 versus DMSO, based on RNA-seq analysis (|log₂FC|> 1, P < 0.05). B KEGG pathway enrichment analysis of DEGs showing involvement in apoptosis and tumor progression. C GSEA analysis indicating significant enrichment of pathways related to apoptotic regulation. D Genome-wide H3K27me3 peak signal profiles from ChIP-seq ( GSE150600 ), showing increased H3K27me3 occupancy at promoter regions and ± 3 kb around transcription start sites following KDM6A/B inhibition. E Heatmap of H3K27me3 signal intensity changes across gene bodies and promoters in the presence or absence of KDM6A/B inhibition. F Venn diagram identifying 13 overlapping genes between downregulated RNA-seq DEGs and genes with increased H3K27me3 peaks, including EGR3 and RBFOX3. G Protein–protein interaction network (STRING database) among overlapping candidates and tumor-related genes, showing co-expression of EGR3 and RBFOX3 with c-FOS (confidence > 0.7), as well as predicted co-expression between KDM6B and c-FOS. H H3K27me3 signal heatmaps for candidate genes (EGR3, RBFOX3, SOX2, MYC, TP53, GATA3) showing increased occupancy, especially at the EGR3 promoter and gene body regions following KDM6A/B inhibition. I Peak signal intensity plots further confirming enhanced H3K27me3 enrichment at EGR3 loci. J Western blot validation of EGR3 and c-FOS downregulation following Gskj1 treatment, accompanied by increased H3K27me3 levels. K Co-immunoprecipitation (Co-IP) analysis demonstrating protein–protein interaction between EGR3 and c-FOS. L Dual-luciferase reporter assay showing EGR3 activates the c-FOS promoter, while mutation abolishes this effect
Anti Egr3 Antibody, supplied by Abmart Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+egr1/anti+egr1/pmc12659317-238-19-21
Average 86 stars, based on 1 article reviews
anti egr3 antibody - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Huabio Inc anti egr1
Gskj1 enhances H3K27me3 enrichment at <t>EGR3</t> and suppresses EGR3/c-FOS signaling to promote apoptosis and ferroptosis. A Volcano plot of differentially expressed genes (DEGs) in H69-AR cells treated with Gskj1 versus DMSO, based on RNA-seq analysis (|log₂FC|> 1, P < 0.05). B KEGG pathway enrichment analysis of DEGs showing involvement in apoptosis and tumor progression. C GSEA analysis indicating significant enrichment of pathways related to apoptotic regulation. D Genome-wide H3K27me3 peak signal profiles from ChIP-seq ( GSE150600 ), showing increased H3K27me3 occupancy at promoter regions and ± 3 kb around transcription start sites following KDM6A/B inhibition. E Heatmap of H3K27me3 signal intensity changes across gene bodies and promoters in the presence or absence of KDM6A/B inhibition. F Venn diagram identifying 13 overlapping genes between downregulated RNA-seq DEGs and genes with increased H3K27me3 peaks, including EGR3 and RBFOX3. G Protein–protein interaction network (STRING database) among overlapping candidates and tumor-related genes, showing co-expression of EGR3 and RBFOX3 with c-FOS (confidence > 0.7), as well as predicted co-expression between KDM6B and c-FOS. H H3K27me3 signal heatmaps for candidate genes (EGR3, RBFOX3, SOX2, MYC, TP53, GATA3) showing increased occupancy, especially at the EGR3 promoter and gene body regions following KDM6A/B inhibition. I Peak signal intensity plots further confirming enhanced H3K27me3 enrichment at EGR3 loci. J Western blot validation of EGR3 and c-FOS downregulation following Gskj1 treatment, accompanied by increased H3K27me3 levels. K Co-immunoprecipitation (Co-IP) analysis demonstrating protein–protein interaction between EGR3 and c-FOS. L Dual-luciferase reporter assay showing EGR3 activates the c-FOS promoter, while mutation abolishes this effect
Anti Egr1, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+egr1/anti+egr1/pm41243575-66-14-16
Average 86 stars, based on 1 article reviews
anti egr1 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Biocare Medical egr1
Gskj1 enhances H3K27me3 enrichment at <t>EGR3</t> and suppresses EGR3/c-FOS signaling to promote apoptosis and ferroptosis. A Volcano plot of differentially expressed genes (DEGs) in H69-AR cells treated with Gskj1 versus DMSO, based on RNA-seq analysis (|log₂FC|> 1, P < 0.05). B KEGG pathway enrichment analysis of DEGs showing involvement in apoptosis and tumor progression. C GSEA analysis indicating significant enrichment of pathways related to apoptotic regulation. D Genome-wide H3K27me3 peak signal profiles from ChIP-seq ( GSE150600 ), showing increased H3K27me3 occupancy at promoter regions and ± 3 kb around transcription start sites following KDM6A/B inhibition. E Heatmap of H3K27me3 signal intensity changes across gene bodies and promoters in the presence or absence of KDM6A/B inhibition. F Venn diagram identifying 13 overlapping genes between downregulated RNA-seq DEGs and genes with increased H3K27me3 peaks, including EGR3 and RBFOX3. G Protein–protein interaction network (STRING database) among overlapping candidates and tumor-related genes, showing co-expression of EGR3 and RBFOX3 with c-FOS (confidence > 0.7), as well as predicted co-expression between KDM6B and c-FOS. H H3K27me3 signal heatmaps for candidate genes (EGR3, RBFOX3, SOX2, MYC, TP53, GATA3) showing increased occupancy, especially at the EGR3 promoter and gene body regions following KDM6A/B inhibition. I Peak signal intensity plots further confirming enhanced H3K27me3 enrichment at EGR3 loci. J Western blot validation of EGR3 and c-FOS downregulation following Gskj1 treatment, accompanied by increased H3K27me3 levels. K Co-immunoprecipitation (Co-IP) analysis demonstrating protein–protein interaction between EGR3 and c-FOS. L Dual-luciferase reporter assay showing EGR3 activates the c-FOS promoter, while mutation abolishes this effect
Egr1, supplied by Biocare Medical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+egr1/anti+anti+anti+egr1/pm23945289-201-25-32
Average 86 stars, based on 1 article reviews
egr1 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

N/A
Rabbit anti-Human EGR1 Polyclonal Antibody
  Buy from Supplier

N/A
Rabbit anti-Human EGR1/EGR2 Polyclonal Antibody
  Buy from Supplier

Image Search Results


The protein expression of emotion-related genes in the hippocampus. ( A ) The protein expression of BDNF, DCX, and EGR1 in hippocampal tissues. ( B – D ) The protein density was quantified using Image J software. BA means baicalin (n = 3). Results are presented as mean ± SE. * p < 0.05, ** p < 0.01, *** p < 0.001. Absence of * indicates no significance.

Journal: Animals : an Open Access Journal from MDPI

Article Title: Effects of Different Ways of Music Stimulation on Exploring, Playing and Aggressive Behavior

doi: 10.3390/ani15182721

Figure Lengend Snippet: The protein expression of emotion-related genes in the hippocampus. ( A ) The protein expression of BDNF, DCX, and EGR1 in hippocampal tissues. ( B – D ) The protein density was quantified using Image J software. BA means baicalin (n = 3). Results are presented as mean ± SE. * p < 0.05, ** p < 0.01, *** p < 0.001. Absence of * indicates no significance.

Article Snippet: EGR1 , 1:1000 , 82 , rabbit , WANLEIBIO, Shenyang, China.

Techniques: Expressing, Software

Gskj1 enhances H3K27me3 enrichment at EGR3 and suppresses EGR3/c-FOS signaling to promote apoptosis and ferroptosis. A Volcano plot of differentially expressed genes (DEGs) in H69-AR cells treated with Gskj1 versus DMSO, based on RNA-seq analysis (|log₂FC|> 1, P < 0.05). B KEGG pathway enrichment analysis of DEGs showing involvement in apoptosis and tumor progression. C GSEA analysis indicating significant enrichment of pathways related to apoptotic regulation. D Genome-wide H3K27me3 peak signal profiles from ChIP-seq ( GSE150600 ), showing increased H3K27me3 occupancy at promoter regions and ± 3 kb around transcription start sites following KDM6A/B inhibition. E Heatmap of H3K27me3 signal intensity changes across gene bodies and promoters in the presence or absence of KDM6A/B inhibition. F Venn diagram identifying 13 overlapping genes between downregulated RNA-seq DEGs and genes with increased H3K27me3 peaks, including EGR3 and RBFOX3. G Protein–protein interaction network (STRING database) among overlapping candidates and tumor-related genes, showing co-expression of EGR3 and RBFOX3 with c-FOS (confidence > 0.7), as well as predicted co-expression between KDM6B and c-FOS. H H3K27me3 signal heatmaps for candidate genes (EGR3, RBFOX3, SOX2, MYC, TP53, GATA3) showing increased occupancy, especially at the EGR3 promoter and gene body regions following KDM6A/B inhibition. I Peak signal intensity plots further confirming enhanced H3K27me3 enrichment at EGR3 loci. J Western blot validation of EGR3 and c-FOS downregulation following Gskj1 treatment, accompanied by increased H3K27me3 levels. K Co-immunoprecipitation (Co-IP) analysis demonstrating protein–protein interaction between EGR3 and c-FOS. L Dual-luciferase reporter assay showing EGR3 activates the c-FOS promoter, while mutation abolishes this effect

Journal: Cell & Bioscience

Article Title: KDM6B inhibition enhances chemotherapeutic response in small cell lung cancer via epigenetic regulation of apoptosis and ferroptosis

doi: 10.1186/s13578-025-01496-6

Figure Lengend Snippet: Gskj1 enhances H3K27me3 enrichment at EGR3 and suppresses EGR3/c-FOS signaling to promote apoptosis and ferroptosis. A Volcano plot of differentially expressed genes (DEGs) in H69-AR cells treated with Gskj1 versus DMSO, based on RNA-seq analysis (|log₂FC|> 1, P < 0.05). B KEGG pathway enrichment analysis of DEGs showing involvement in apoptosis and tumor progression. C GSEA analysis indicating significant enrichment of pathways related to apoptotic regulation. D Genome-wide H3K27me3 peak signal profiles from ChIP-seq ( GSE150600 ), showing increased H3K27me3 occupancy at promoter regions and ± 3 kb around transcription start sites following KDM6A/B inhibition. E Heatmap of H3K27me3 signal intensity changes across gene bodies and promoters in the presence or absence of KDM6A/B inhibition. F Venn diagram identifying 13 overlapping genes between downregulated RNA-seq DEGs and genes with increased H3K27me3 peaks, including EGR3 and RBFOX3. G Protein–protein interaction network (STRING database) among overlapping candidates and tumor-related genes, showing co-expression of EGR3 and RBFOX3 with c-FOS (confidence > 0.7), as well as predicted co-expression between KDM6B and c-FOS. H H3K27me3 signal heatmaps for candidate genes (EGR3, RBFOX3, SOX2, MYC, TP53, GATA3) showing increased occupancy, especially at the EGR3 promoter and gene body regions following KDM6A/B inhibition. I Peak signal intensity plots further confirming enhanced H3K27me3 enrichment at EGR3 loci. J Western blot validation of EGR3 and c-FOS downregulation following Gskj1 treatment, accompanied by increased H3K27me3 levels. K Co-immunoprecipitation (Co-IP) analysis demonstrating protein–protein interaction between EGR3 and c-FOS. L Dual-luciferase reporter assay showing EGR3 activates the c-FOS promoter, while mutation abolishes this effect

Article Snippet: For each immunoprecipitation reaction, 500–1000 μg of total protein was incubated overnight at 4 °C with 2–5 μg of anti-EGR3 antibody (Abmart, #PK44695) or anti-c-FOS antibody (Abmart, # T56596 ).

Techniques: RNA Sequencing, Genome Wide, ChIP-sequencing, Inhibition, Expressing, Western Blot, Biomarker Discovery, Immunoprecipitation, Co-Immunoprecipitation Assay, Luciferase, Reporter Assay, Mutagenesis